Coca-Cola Japan is partnering with Kirin Holdings to develop a functional beverage that contains postbiotic bacteria, according to Nikkei Asia.
Kirin’s LC-Plasma – or Lactococcus lactis strain plasma – is a patented bacteria that is currently used in the company’s health drinks. The Japanese beverage company claims that the bacteria helps to boost immunity in healthy consumers.
Coca-Cola plans to use LC-Plasma in three of its brands, Georgia, Irohasu and Minute Maid.
Kirin was given approval by Japan’s Consumer Affairs Agency in 2020 to advertise its healthy beverage products that contain the strain.
The company has already sold its ingredient to Taisho Pharmaceutical Holdings, as well as companies such as Morinaga and Kanro.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial